In addition, the ratios of TG/HDL-C, TC/HDL-C, FFA/HDL-C, LDL-C/HDL-C, UA/HDL-C, APOB/A1 were significantly higher in new-onset T2DM patients with NAFLD than in patients without NAFLD (Table 1). The gene discussed is APOB; the disease is metabolic dysfunction-associated steatotic liver disease.